Search This Site:

High Cost Drugs & IFR

High Cost Drugs & IFR

High Cost Drug Commissioning and Individual Funding Requests

High Cost Drugs

High cost drugs (HCDs) are drugs excluded from the National Tariff for which the CCG is the responsible commissioner. For high cost drugs that are routinely commissioned by the CCG, completion of an electronic form via Blueteq is the preferred method of request. Further information on local CCG routinely commissioned policies for high cost drugs can be found on the JPC & PAG, Prescribing Information, Bulletins and Guidance and Clinical Guidelines and Pathways pages.

For Trusts who are not currently operating Blueteq, please request a paper proforma via the relevant CCG place-based team:

Upon completion, paper proformas should be sent to the IFR co-ordinating teams for processing:

If an HCD request is for an indication that is not routinely commissioned and it applies to a group of patients (rather than an individual), a business case should be submitted to the CCG for consideration. Please contact the relevant CCG place-based team via the contact details above.


Where a particular patient does not meet routine commissioning criteria for a High Cost Drug and the Trust specialist/consultant believes there is an exceptional clinical circumstance, an individual funding request can be submitted to the CCG for consideration.  Please contact the relevant IFR coordinating team (details listed above) for an application form and information on the application process.


The BLMK Specialist Drugs list for Hospital initiation/GP prescribing is here

If the papers you require are not here, please contact the Medicines Management Team: or 01525 624 375

Read Our Latest News

Scroll to Top